SB 1100
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
SB 1100
Continuity of care
California · Failed
Lobbied on it8 of 9
California Life Sciences3 reportsDaiichi Sankyo Inc.2 reportsMedtronic, Inc.2 reportsAstellas Pharma US, Inc.1 reportBoehringer Ingelheim Pharmaceuticals, Inc.1 reportCalifornia Primary Care Association and Affiliated Entity California Primary Care Association Advocates1 reportMarch of Dimes1 reportOtsuka America Pharmaceutical, Inc.1 reportEvery link on this map
The same connections as a table, with the reason each one is here.
| Ed Hernandez | Sponsors | Ed Hernandez sponsored SB 1100. | None |
| California Life Sciences | Lobbied on it | California Life Sciences named SB 1100 in 3 lobbying reports. | 3 reports |
| Daiichi Sankyo Inc. | Lobbied on it | Daiichi Sankyo Inc. named SB 1100 in 2 lobbying reports. | 2 reports |
| Medtronic, Inc. | Lobbied on it | Medtronic, Inc. named SB 1100 in 2 lobbying reports. | 2 reports |
| Astellas Pharma US, Inc. | Lobbied on it | Astellas Pharma US, Inc. named SB 1100 in 1 lobbying report. | 1 report |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Lobbied on it | Boehringer Ingelheim Pharmaceuticals, Inc. named SB 1100 in 1 lobbying report. | 1 report |
| California Primary Care Association and Affiliated Entity California Primary Care Association Advocates | Lobbied on it | California Primary Care Association and Affiliated Entity California Primary Care Association Advocates named SB 1100 in 1 lobbying report. | 1 report |
| March of Dimes | Lobbied on it | March of Dimes named SB 1100 in 1 lobbying report. | 1 report |
| Otsuka America Pharmaceutical, Inc. | Lobbied on it | Otsuka America Pharmaceutical, Inc. named SB 1100 in 1 lobbying report. | 1 report |